Myrtenal downregulates hormonal receptors in DMBA induced mammary carcinoma in Sprague-Dawley rats
Paper Details
Myrtenal downregulates hormonal receptors in DMBA induced mammary carcinoma in Sprague-Dawley rats
Abstract
Myrtenal, a natural phytocompound, has shown promising biological activities, including antioxidant and anti-inflammatory properties, which could be beneficial in modulating cancer-related pathways. This study evaluates the dose-dependent effects of myrtenal on the immunoexpression pattern of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2/neu), in the mammary tissues of mammary tumor bearing Sprague-Dawley rats. This study induced mammary carcinoma in Sprague-Dawley rats by injecting a single subcutaneous injection of 7,12-dimethylbenz(a)anthracene (DMBA; 25 mg/kg body weight) in the mammary gland. Immunohistochemical analysis revealed that all the three hormonal receptors were overexpressed in breast tissues of rats treated with DMBA alone. Oral administration of myrtenal at different doses (100, 200 and 400 mg/kg body weight) resulted in dose-dependent downregulation. These findings suggest that myrtenal has shown potent anticancer effect by modulating the expression of receptors in DMBA induced triple positive breast cancer.
Abba MC, Zhong Y, Lee J, Kil H, Lu Y, Takata Y, Simper MS, Gaddis S, Shen J, Aldaz CM. 2016. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations. Oncotarget 7(39), 64289–64299.
Acs B, Hartman J, Sönmez D, Lindman H, Johansson ALV, Fredriksson I. 2024. Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study. The Lancet regional health. Europe 40, 100886.
Adefisan-Adeoye AO, Ayanbanjo OO, Adeoye TD, Jayesimi TE, Unuofin JO, Lebelo SL, Adaramoye OA. 2025. Bisdemethoxycurcumin chemoprevents 7,12-dimethylbenz(a)anthracene-induced mammary toxicity via modulation of oxidative processes. Scientific reports 15(1), 9170.
Al-Shami K, Awadi S, Khamees A, Alsheikh AM, Al-Sharif S, Ala’ Bereshy R, Al-Eitan SF, Banikhaled SH, Al-Qudimat AR, Al-Zoubi RM, Al Zoubi MS. 2023. Estrogens and the risk of breast cancer: A narrative review of literature. Heliyon 9(9), e20224.
Atuahene D, Mahama K, Sam BA, Appiah DA, Pandey VK, Bela K, Harsányi E, Shaikh AM. 2025. Dietary targeting of cancer pathways: Role of bioactive compounds and nutraceuticals. Food and Humanity 5, 100748.
Conzen SD. 2008. Minireview: nuclear receptors and breast cancer. Molecular endocrinology (Baltimore, Md.) 22(10), 2215–2228.
Dang Cong T, Nguyen Thanh T, Nguyen Phan QA, Hoang Thi AP, Nguyen Tran BS, Nguyen Vu QH. 2020. Correlation between HER2 Expression and Clinicopathological Features of Breast Cancer: A Cross- Sectional Study in Vietnam. Asian Pacific journal of cancer prevention: APJCP 21(4), 1135–1142.
Dragomanova S, Andonova V, Volcho K, Salakhutdinov N, Kalfin R, Tancheva L. 2023. Therapeutic Potential of Myrtenal and Its Derivatives-A Review. Life (Basel, Switzerland), 13(10), 2086.
Dragomanova S, Tancheva L, Georgieva M. 2018. A review: Biological activity of myrtenal and some myrtenal-containing medicinal plant essential oils. Scripta Scientifica Pharmaceutica 5(2), 22.
Fry EA, Taneja P, Inoue K. 2016. Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu. International Journal of Cancer 140(3), 495–503.
Geyer FC, Rodrigues DN, Weigelt B, Reis-Filho JS. 2012. Molecular classification of estrogen receptor-positive/luminal breast cancers. Advances in anatomic pathology 19(1), 39–53.
Hamza AA, Khasawneh MA, Elwy HM, Hassanin SO, Elhabal SF, Fawzi NM. 2022. Salvadora persica attenuates DMBA-induced mammary cancer through downregulation oxidative stress, estrogen receptor expression and proliferation and augmenting apoptosis. Biomedicine & pharmacotherapy= Biomedecine & pharmacotherapie 147, 112666.
Haque M, Atallah N, Patke R, Harris AE, Woodcock CL, Varun D, Thompson RL, Jackson-Oxley J, Okui CH, Dean A, Alsaleem M, Rakha E, Irshad S, Davis MB, Jeyapalan JN, Mongan NP, Rutland CS. 2025. Cardiotoxicity of breast cancer drug treatments. Translational oncology 55, 102352.
Hashim GM, Shahgolzari M, Hefferon K, Yavari A, Venkataraman S. 2025. Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals. Bioengineering 12(1), 7.
Hou Y, Li J, Zhang Q, Fan Y. 2025. Association of progesterone receptor status with breast cancer prognosis: a meta-analysis. World journal of surgical oncology 23(1), 356.
Hou Y, Nitta H, Li Z. 2023. HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept. Cancers 15(10), 2664.
Iqbal J, Abbasi BA, Mahmood T, Kanwal S, Ali B, Shah SA, Khalil AT. 2017. Plant-derived anticancer agents: A green anticancer approach. Asian Pacific Journal of Tropical Biomedicine 7(12), 1129–1150.
Kay JE, Cardona B, Rudel RA, Vandenberg LN, Soto AM, Christiansen S, Birnbaum LS, Fenton SE. 2022. Chemical Effects on Breast Development, Function, and Cancer Risk: Existing Knowledge and New Opportunities. Current environmental health reports 9(4), 535–562.
Kesireddy M, Masih D, Shostrom VK, Yellala A, Asif S, Krishnamurthy J. 2025. Overall Survival and Prognostic Factors in De Novo Metastatic Human Epidermal Growth Factor Receptor (HER)-2-Positive Breast Cancer: A National Cancer Database Analysis. Cancers 17(11), 1823.
Kim J, Munster PN. 2025. Estrogens and breast cancer. Annals of oncology: official journal of the European Society for Medical Oncology, 36(2), 134–148.
Kim N, Lukong KE. 2025. Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action. Oncology reviews 19, 1564642.
Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, Mutebi M, Garvey G, Soerjomataram I, Fidler-Benaoudia MM. 2025. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature medicine 31(4), 1154–1162.
Korkmaz E, Tekin S. 2024. Cytotoxicity of myrtenal on different human cancer cell lines. Annals of Medical Research 31(5), 404.
Kunstič TT, Debeljak N, Tacer KF. 2023. Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors. Advances in Cancer Biology – Metastasis 7(6), 100086.
Lakshmi A, Subramanian S. 2013. Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. Biochimie 99, 96–109.
Li Z, Wei H, Li S, Wu P, Mao X. 2022. The Role of Progesterone Receptors in Breast Cancer. Drug design, development and therapy 16, 305–314.
Lin G, Duan W, Yang L, Huang M, Lei F. 2017. Synthesis and antifungal activity of novel Myrtenal-Based 4-Methyl-1,2,4-triazole-thioethers. Molecules 22(2), 193.
Lu Z, Yang J, Feng Y, Ming J. 2025. Integrated proteomics and transcriptomics analysis reveals key regulatory genes between ER-positive/PR-positive and ER-positive/PR-negative breast cancer. BMC Cancer 25(1), 1-12.
Maaruf NA, Najjar SM, Ali SA. 2023. Anatomical and Histopathological Comparative Studies Between Right and Left Mammary Tumors in a Rat Model Induced by DMBA. Pakistan Veterinary Journal 43(2), 232-240.
Machado TQ, da Fonseca ACC, Duarte ABS, Robbs BK, de Sousa DP. 2022. A Narrative Review of the Antitumor Activity of Monoterpenes from Essential Oils: An Update. BioMed research international 2022 (1), 1-20.
Malik P, Mukherjee TK. 2025. Exogenous Estrogens as Breast Cancer Risk Factors: A Perspective. Cancers 17(16), 2680.
Mangani S, Piperigkou Z, Koletsis NE, Ioannou P, Karamanos NK. 2025. Estrogen receptors and extracellular matrix: the critical interplay in cancer development and progression. The FEBS journal 292(7), 1558–1572.
Mashat RM, Zielinska HA, Holly JMP, Perks CM. 2021. A role for ER-Beta in the effects of Low-Density lipoprotein cholesterol and 27-Hydroxycholesterol on breast cancer progression: involvement of the IGF signalling pathway? Cells 11(1), 94.
Miziak P, Baran M, Błaszczak E, Przybyszewska-Podstawka A, Kałafut J, Smok-Kalwat J, Dmoszyńska-Graniczka M, Kiełbus M, Stepulak A. 2023. Estrogen Receptor Signaling in Breast Cancer. Cancers 15(19), 4689.
Obeagu EI, Obeagu GU. 2024. Breast cancer: A review of risk factors and diagnosis. Medicine 103(3), e36905.
Pegram M, Jackisch C, Johnston SRD. 2023. Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer. Npj Breast Cancer 9(1), 45.
Pethanasamy M, Sivasankaran SM, Surya S, Kowsalya R. 2025. Tumor suppressing ability of myrtenal in DMBA-induced rat mammary cancer: A biochemical and histopathological evaluation. International Journal of Biosciences 27(2), 141–150.
Platet N, Cathiard AM, Gleize M, Garcia M. 2004. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Critical Reviews in Oncology/Hematology 51(1), 55–67.
Purdie CA, Quinlan P, Jordan LB, Ashfield A, Ogston S, Dewar JA, Thompson AM. 2013. Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. British Journal of Cancer 110(3), 565–572.
Rubin E, Shan KS., Dalal S, Vu DUD, Milillo-Naraine AM, Guaqueta D, Ergle A. 2024. Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers. International Journal of Molecular Sciences 25(2), 1064.
Russo J. 2015. Significance of rat mammary tumors for human risk assessment. Toxicologic pathology 43(2), 145–170.
Sewoyo PS, Purwanti NLL, Munawaroh M, Kardena IM, Astawa INM. 2024. Establishment of Mammary Tumors by Injection of 7,12-Dimethylbenz[a]anthracene in Mammary Fat Pad of Rats. World S Veterinary Journal 14(4), 490–497.
Shaban NZ, El-Rashidy FH, Adam AH, Beltagy DM, Ali AE, Abde-Alaziz AA, Talaat IM. 2023. Anticancer role of mango (Mangifera indica L.) peel and seed kernel extracts against 7,12- dimethylbenz[a]anthracene-induced mammary carcinogenesis in female rats. Scientific reports 13(1), 7703.
Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. 2025. Cancer statistics, 2025. CA: a cancer journal for clinicians 75(1), 10–45.
Srinivasan R, Chaitanyakumar A, Mageswari A, Gomathi A, Pavan Kumar JGS, Jayasindu M, Bharath G, Shravan JS, Gothandam KM. 2017. Oral administration of lyophilized Dunaliella salina, a carotenoid-rich marine alga, reduces tumor progression in mammary cancer induced rats. Food & Function 8(12), 4517–4527.
Swain SM, Shastry M, Hamilton E. 2022. Targeting HER2-positive breast cancer: advances and future directions. Nature Reviews Drug Discovery 22(2), 101–126.
Thakkar JP, Mehta DG. 2011. A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative. The Oncologist 16(3), 276–285.
Thangarasu R, Pachaiappan P, Subbaiyan T. 2020. Anti-Estrogenic and Anti-Cell Proliferative Effect of Allyl Isothiocyanate in Chemoprevention of Chemically Induced Mammary Carcinogenesis in Rats. Pathology Oncology Research: POR 26(2), 913–925.
Vemula S, Dhakshanamoorthy K. 2025. Epidemiology of Cancer Incidence Estimates and Statistics 2000–2025: Analysis from National Cancer Registry Programme in India. Indian Journal of Medical and Paediatric Oncology 46(03), 278–287.
Wakasa M, Masaki M, Kajinami K. 2025. Trastuzumab Cardiotoxicity: Mechanism and Management. Biological & Pharmaceutical Bulletin 48(9), 1287–1294.
Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD. 2025. Breast cancer: pathogenesis and treatments. Signal Transduction And Targeted Therapy 10(1), 49.
Ye F, Chen X, Cao Y, You Z, Lai J. 2025. The global, regional, and national disease burden of breast cancer attributable to behavioral risks from 1990 to 2021 and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021. Breast Cancer (Tokyo, Japan) 32(6), 1434–1447.
Manoharan Pethanasamy, Shanmugam M. Sivasankaran, Saravanan Surya, Raju Kowsalya, 2025. Myrtenal downregulates hormonal receptors in DMBA induced mammary carcinoma in Sprague-Dawley rats. J. Biodiv. Environ. Sci., 27(5), 143-151.
Copyright © 2025 by the Authors. This article is an open access article and distributed under the terms and conditions of the Creative Commons Attribution 4.0 (CC BY 4.0) license.